Table 2.
Drug | Diameter | Phasic activity | Lymph flow velocity |
Sodium Nitroprusside (10-5 mol/L) | Dilation | Slight short-time inhibition | Unchanged |
N-Nitro-L-Arginine (10-4 mol/L) | Unchanged | Stimulation | Stimulation |
Isoprenaline (10-5 mol/L) | Constriction | Inhibition | Inhibition up to stasis |
Metoprolol (10-5 mol/L) | Unchanged | Stimulation | Stimulation |
Butoxamin (10-5 mol/L) | Unchanged | Slight stimulation | Unchanged |
Dymethyl Sulfoxide, (30%) | Constriction | Stimulation | Stimulation in 50% of lymphangions |
Inhibition in 39% of lymphangions (without phasic contractions) |